Tag: AffloVest

MINNEAPOLIS – Tactile Medical’s acquisition of AffloVest positions the company in another underpenetrated market that treats patients with chronic diseases in their homes, says Eric Pauls, senior vice president of sales.  Tactile Medical says, of the more than 16 million people living with COPD in the United States, more than 4 million may be affected by bronchiectasis, a respiratory disease that can be treated with AffloVest, a wearable, battery powered high frequency chest wall...

MINNEAPOLIS – Tactile Medical has acquired the assets of the AffloVest respiratory therapy business from International Biophysics Corp., a privately held company that developed and manufactures the portable, wearable vest.  AffloVest is used to treat patients with chronic respiratory conditions such as COPD-associated breathing conditions like bronchiectasis, or conditions resulting from neuromuscular disorders and cystic fibrosis, by managing airway clearance.  “The addition...